News | July 11, 2022
India’s first homegrown mRNA COVID-19 vaccine likely to have low market penetration, says GlobalData
Proportion of the eligible population yet to receive a COVID-19 vaccine is comparatively small
Proportion of the eligible population yet to receive a COVID-19 vaccine is comparatively small
MINYM can be safely used by patients above 9 years of age.
_256_384.png)
Researchers from Bar-Ilan University find that even in old age, feeling young can lower the risks of developing physical disability and morbidity
_256_384.jpg)
Mittal has previously managed Multiple backed Vikram Hospital as CEO and was associated with Fortis Escorts Heart Institute as zonal director.
This multicenter, open-label Phase I study is designed to assess the safety and tolerability
A newly revealed mechanism by Weizmann Institute of Science of ketamine’s action on potassium channels in neurons may lead to improved therapies for depression
Analysis of Post-Marketing Safety Data Shows Consistent Findings with Safety Profile Reported in Clinical Trials of Edaravone
Strengthens investment in channels of the future to expand patient reach
An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56.
V116 designed to target serotypes that account for 85% of all invasive pneumococcal disease in individuals aged 65 and over in the United States as of 2019
Subscribe To Our Newsletter & Stay Updated
